EcoDrugPlus

Kelch Like Ech Associated Protein 1

Ensembl ID : ENSCLAG00000011003
Gene Symbol: KEAP1
2 Cross references
189 Possible Orthologues:

Kinase Insert Domain Receptor

Ensembl ID : ENSCLAG00000010052
Gene Symbol: KDR
2 Cross references
199 Possible Orthologues:

Kinesin Family Member 11

Ensembl ID : ENSCLAG00000013622
Gene Symbol: KIF11
2 Cross references
203 Possible Orthologues:

Kinesin Family Member 5b

Ensembl ID : ENSCLAG00000009833
Gene Symbol: KIF5B
2 Cross references
288 Possible Orthologues:

Leukocyte Immunoglobulin-Like Receptor Subfamily A Member 2

Ensembl ID : ENSCLAG00000001076
Gene Symbol: LOC102008784
1 Cross references
103 Possible Orthologues:

Leukocyte Immunoglobulin-Like Receptor Subfamily B Member 3

Ensembl ID : ENSCLAG00000001196
Gene Symbol: LOC102007948
1 Cross references
103 Possible Orthologues:

Leukotriene A4 Hydrolase

Ensembl ID : ENSCLAG00000011828
Gene Symbol: LTA4H
1 Cross references
207 Possible Orthologues:

Leukotriene B4 Receptor

Ensembl ID : ENSCLAG00000017796
Gene Symbol: LTB4R
2 Cross references
141 Possible Orthologues:

Leukotriene B4 Receptor 2

Ensembl ID : ENSCLAG00000009760
Gene Symbol: LTB4R2
3 Cross references
238 Possible Orthologues:

Lysine Demethylase 1a

Ensembl ID : ENSCLAG00000007181
Gene Symbol: KDM1A
2 Cross references
214 Possible Orthologues:

Lysyl Oxidase Like 2

Ensembl ID : ENSCLAG00000016283
Gene Symbol: LOXL2
2 Cross references
288 Possible Orthologues:

Macrophage Migration Inhibitory Factor

Ensembl ID : ENSCLAG00000009103
Gene Symbol: MIF
3 Cross references
220 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).